Aspen Neuroscience Uses MRI-Guided ClearPoint Navigation System For Patients Enrolled In ASPIRO Phase 1/2a Clinical Trial For Transplantation Of Dopaminergic Neuron Precursor Cells In Patients With Parkinson's Disease
Aspen Neuroscience Uses MRI-Guided ClearPoint Navigation System For Patients Enrolled In ASPIRO Phase 1/2a Clinical Trial For Transplantation Of Dopaminergic Neuron Precursor Cells In Patients With Parkinson's Disease
Aspen Neuroscience在ASPIRO 1/2a臨床試驗中爲帕金森病患者移植多巴胺能神經元前體細胞，使用MRI引導的ClearPoint導航系統。
Aspen Neuroscience Announces MRI-Guided Transplantation Approach for ASPIRO Clinical Trial with the ClearPoint Navigation System
Aspen Neuroscience宣佈使用ClearPoint導航系統的MRI引導移植方法進行ASPIRO臨床試驗
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。